Background and Objective: Hemodialysis (HD) patients are more inactive, leading to poor functional capacity and quality of life; this may be reversed with intradialytic exercise training. To systematically evaluate the efficacy and safety of intradialytic exercise for HD patients, we conducted a meta-analysis of the published randomized controlled trials. Data Sources and Methods: Medline, Embase, and Cochrane Central Register of Controlled Trials were systematically searched up to February, 2014. The reference lists of eligible studies and relevant reviews were also checked. Results: 24 studies of 997 patients were included. Compared with control, intradialytic exercise significantly improve Kt/V (SMD = 0.27, 95% CI 0.01-0.53), peak oxygen consumption (VO2peak) (SMD = 0.53, 95% CI 0.30-0.76), and physical performance of physical function of life (SMD = 0.30, 95% CI 0.04-0.55). However, no significant improvements were found in the mental function of life. There was no significant difference with respect to musculoskeletal and cardiovascular complications between the intradialytic exercise groups and control groups. Further subgroup analysis found that, when the trial duration was more than 6 months, the intervention had significant effects on VO2peak (SMD = 0.89, 95% CI 0.56-1.22). However, when the trial duration was less than 6 months, the change of VO2peak was not significant (SMD = 0.19, 95% CI -0.13 to 0.51). Conclusion: Intradialytic exercise can improve Kt/V, VO2peak, and the physical quality of life, and intradialytic exercise is safe for HD patients. Therefore, we put forward the suggestion that clinical guideline be updated to inform clinicians on the benefits of intradialytic exercise on HD patients. i 2014 S. Karger AG, Basel

1.
O'Hare AM, Tawney K, Bacchetti P, et al: Decreased survival among sedentary patients undergoing dialysis: results from the dialysis morbidity and mortality study wave 2. Am J Kidney Dis 2003;41:447-454.
2.
Stack AG, Molony DA, Rives T, Tyson J, Murthy BV: Association of physical activity with mortality in the US dialysis population. Am J Kidney Dis 2005;45:690-701.
3.
Kouidi EJ, Grekas DM, Deligiannis AP: Effects of exercise training on noninvasive cardiac measures in patients undergoing long-term hemodialysis: a randomized controlled trial. Am J Kidney Dis 2009;54:511-521.
4.
Mohseni R, Emami Zeydi A, Ilali E, Adib-Hajbaghery M, Makhlough A: The effect of intradialytic aerobic exercise on dialysis efficacy in hemodialysis patients: a randomized controlled trial. Oman Med J 2013;28:345-349.
5.
Pellizzaro CO, Thome FS, Veronese FV: Effect of peripheral and respiratory muscle training on the functional capacity of hemodialysis patients. Ren Fail 2013;35:189-197.
6.
Song WJ, Sohng KY: Effects of progressive resistance training on body composition, physical fitness and quality of life of patients on hemodialysis. J Korean Acad Nurs 2012;42:947-956.
7.
Afshar R, Shegarfy L, Shavandi N, et al: Effects of aerobic exercise and resistance training on lipid profiles and inflammation status in patients on maintenance hemodialysis. Indian J Nephrol 2010;20:185-189.
8.
Konstantinidou E, Koukouvou G, Kouidi E, et al: Exercise training in patients with end-stage renal disease on hemodialysis: comparison of three rehabilitation programs. J Rehabil Med 2002;34:40-45.
9.
Painter PL, Nelson-Worel JN, Hill MM, et al: Effects of exercise training during hemodialysis. Nephron 1986;43:87-92.
10.
Parsons TL, Toffelmire EB, King-VanVlack CE: Exercise training during hemodialysis improves dialysis efficacy and physical performance. Arch Phys Med Rehabil 2006;87:680-687.
11.
Koh KP, Fassett RG, Sharman JE, Coombes JS, et al: Effect of intradialytic versus home-based aerobic exercise training on physical function and vascular parameters in hemodialysis patients: a randomized pilot study. Am J Kidney Dis 2010;55:88-99.
12.
Cheema BS, Singh MA: Exercise training in patients receiving maintenance hemodialysis: a systematic review of clinical trials. Am J Nephrol 2005;25:352-364.
13.
Segura-Orti E: Exercise in haemodyalisis patients: a literature systematic review. Nefrologia 2010;30:236-246.
14.
Smart N, Steele M: Exercise training in haemodialysis patients: a systematic review and meta-analysis. Nephrology (Carlton) 2011;16:626-632.
15.
Maher CG, Sherrington C, Herbert RD, et al: Reliability of the PEDro scale for rating quality of randomized controlled trials. Phys Ther 2003;83:713-721.
16.
Alderson P, Green S: Cochrane Collaboration Open Learning Material for Reviewers. Version 1.1, 2002. www.cochrane.org (accessed September 10, 2005).
17.
Kouidi E, Karagiannis V, Grekas D, et al: Depression, heart rate variability, and exercise training in dialysis patients. Eur J Cardiovasc Prev Rehabil 2010;17:160-167.
18.
Cheema B, Abas H, Smith B, et al: Progressive exercise for anabolism in kidney disease (PEAK): a randomized, controlled trial of resistance training during hemodialysis. J Am Soc Nephrol 2007;18:1594-1601.
19.
Chen JL, Godfrey S, Ng TT, et al: Effect of intra-dialytic, low-intensity strength training on functional capacity in adult haemodialysis patients: a randomized pilot trial. Nephrol Dial Transplant 2010;25:1936-1943.
20.
De Lima MC, Cicotoste Cde L, Cardoso Kda S, et al: Effect of exercise performed during hemodialysis: strength versus aerobic. Ren Fail 2013;35:697-704.
21.
DePaul V, Moreland J, Eager T, Clase CM: The effectiveness of aerobic and muscle strength training in patients receiving hemodialysis and EPO: a randomized controlled trial. Am J Kidney Dis 2002;40:1219-1229.
22.
Giannaki CD, Hadjigeorgiou GM, Karatzaferi C, et al: A single-blind randomized controlled trial to evaluate the effect of 6 months of progressive aerobic exercise training in patients with uraemic restless legs syndrome. Nephrol Dial Transplant 2013;28:2834-2840.
23.
Giannaki CD, Sakkas GK, Karatzaferi C, et al: Effect of exercise training and dopamine agonists in patients with uremic restless legs syndrome: a six-month randomized, partially double-blind, placebo-controlled comparative study. BMC Nephrol 2013;14:194.
24.
Johansen KL, Painter PL, Sakkas GK, et al: Effects of resistance exercise training and nandrolone decanoate on body composition and muscle function among patients who receive hemodialysis: a randomized, controlled trial. J Am Soc Nephrol 2006;17:2307-2314.
25.
Koufaki P, Mercer TH, Naish PF: Effects of exercise training on aerobic and functional capacity of end-stage renal disease patients. Clin Physiol Funct Imaging 2002;22:115-124.
26.
Makhlough A, Ilali E, Mohseni R, Shahmohammadi S: Effect of intradialytic aerobic exercise on serum electrolytes levels in hemodialysis patients. Iran J Kidney Dis 2012;6:119-123.
27.
Ouzouni S, Kouidi E, Sioulis A, Grekas D, Deligiannis A: Effects of intradialytic exercise training on health-related quality of life indices in haemodialysis patients. Clin Rehabil 2009;23:53-63.
28.
Petraki M, Kouidi E, Grekas D, Deligiannis A: Effects of exercise training during hemodialysis on cardiac baroreflex sensitivity. Clin Nephrol 2008;70:210-219.
29.
Reboredo Mde M, Pinheiro Bdo V, Neder JA, et al: Effects of aerobic training during hemodialysis on heart rate variability and left ventricular function in end-stage renal disease patients. J Bras Nefrol 2010;32:367-373.
30.
Toussaint ND, Polkinghorne KR, Kerr PG: Impact of intradialytic exercise on arterial compliance and B-type natriuretic peptide levels in hemodialysis patients. Hemodial Int 2008;12:254-263.
31.
Van Vilsteren MC, de Greef MH, Huisman RM: The effects of a low-to-moderate intensity pre-conditioning exercise programme linked with exercise counselling for sedentary haemodialysis patients in The Netherlands: results of a randomized clinical trial. Nephrol Dial Transplant 2005;20:141-146.
32.
Wilund KR, Tomayko EJ, Wu PT, et al: Intradialytic exercise training reduces oxidative stress and epicardial fat: a pilot study. Nephrol Dial Transplant 2010;25:2695-2701.
33.
Egger M, Davey Smith G, Schneider M, et al: Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-634.
34.
Heiwe S, Jacobson SH: Exercise training for adults with chronic kidney disease. Cochrane Database Syst Rev 2011;10:CD003236.
35.
Cheigh JS, Milite C, Sullivan JF, et al: Hypertension is not adequately controlled in hemodialysis patients. Am J Kidney Dis 1992;19:453-459.
36.
Thompson PD, Buchner D, Pina IL, et al: Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity). Circulation 2003;107:3109-3116.
37.
Cornelissen VA, Fagard RH: Effects of endurance training on blood pressure, blood pressure-regulating mechanisms, and cardiovascular risk factors. Hypertension 2005;46:667-675.
38.
Fagard RH: Exercise is good for your blood pressure: effects of endurance training and resistance training. Clin Exp Pharmacol Physiol 2006;33:853-856.
39.
Goldberg AP, Geltman EM, Hagberg JM, et al: Therapeutic benefits of exercise training for hemodialysis patients. Kidney Int Suppl 1983;16:S303-S309.
40.
Hakim RM, Breyer J, Ismail N, Schulman G: Effects of dose of dialysis on morbidity and mortality. Am J Kidney Dis 1994;23:661-669.
41.
Collins AJ, Ma JZ, Umen A, et al: Urea index and other predictors of hemodialysis patient survival. Am J Kidney Dis 1994;23:272-282.
42.
Held PJ, Port FK, Wolfe RA, et al: The dose of hemodialysis and patient mortality. Kidney Int 1996;50:550-556.
43.
Port FK, Ashby VB, Dhingra RK, Roys EC, Wolfe RA: Dialysis dose and body mass index are strongly associated with survival in hemodialysis patients. J Am Soc Nephrol 2002;13:1061-1066.
44.
Eknoyan G, Beck GJ, Cheung AK, et al; Hemodialysis (HEMO) Study Group: Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 2002;347:2010-2019.
45.
Greene T, Daugirdas J, Depner T, Allon M, Beck G, Chumlea C, Delmez J, Gotch F, Kusek JW, Levin N, Owen W, Schulman G, Star R, Toto R, et al: Association of achieved dialysis dose with mortality in the hemodialysis study: an example of ‘dose-targeting bias'. J Am Soc Nephrol 2005;16:3371-3380.
46.
Owen WF Jr, Chertow GM, Lazarus JM, Lowrie EG: Dose of hemodialysis and survival: differences by race and sex. JAMA 1998;280:1764-1768.
47.
Port FK, Wolfe RA, Hulbert-Shearon TE, et al: High dialysis dose is associated with lower mortality among women but not among men. Am J Kidney Dis 2004;43:1014-1023.
48.
Depner T, Daugirdas J, Greene T, et al: Dialysis dose and the effect of gender and body size on outcome in the HEMO study. Kidney Int 2004;65:1386-1394.
49.
Spalding EM, Chandna SM, Davenport A, et al: Kt/V underestimates the hemodialysis dose in women and small men. Kidney Int 2008;74:348-355.
50.
Miller JE, Kovesdy CP, Nissenson AR, et al: Association of hemodialysis treatment time and dose with mortality and the role of race and sex. Am J Kidney Dis 2010;55:100-112.
51.
Segura-Orti E, Kouidi E, Lison JF: Effect of resistance exercise during hemodialysis on physical function and quality of life: randomized controlled trial. Clin Nephrol 2009;71:527-537.
52.
Fotbolcu H, Duman D, Ecder SA, et al: Attenuated cardiovascular response to sympathetic system activation during exercise in patients with dialysis-induced hypotension. Am J Nephrol 2011;33:491-498.
53.
Copley JB, Lindberg JS: The risks of exercise. Adv Ren Replace Ther 1999;6:165-171.
54.
Borg G, Linderholm H: Exercise performance and perceived exertion in patients with coronary insufficiency, arterial hypertension and vasoregulatory asthenia. Acta Med Scand 1970;187:17-26.
55.
Faulkner J, Parfitt G, Eston R: Prediction of maximal oxygen uptake from the ratings of perceived exertion and heart rate during a perceptually-regulated sub-maximal exercise test in active and sedentary participants. Eur J Appl Physiol 2007;101:397-407.
56.
Johansen KL: Exercise in the end-stage renal disease population. J Am Soc Nephrol 2007;18:1845-1854.
57.
Higgins JPT, Green S (eds): Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. http://www.cochrane-handbook.org.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.